ABSTRACT:
INTRODUCTION: Bone is
the most common site of breast cancer metastasis and complications associated
with bone metastases can lead to a significantly decreased patient quality of
life. Thus, it is essential to gain a better understanding of the molecular
mechanisms that underlie the emergence and growth of breast cancer skeletal
metastases.
METHODS:
To search for novel
molecular mediators that influence breast cancer bone metastasis, we generated
gene expression profiles from laser capture microdissected trephine biopsies of
both breast cancer bone metastases and independent primary breast tumours that
metastasized to bone. Bioinformatics analysis identified genes that are
differentially expressed in breast cancer bone metastases compared to primary,
bone metastatic breast tumours.
RESULTS:
ABCC5, an ATP-dependent
transporter, was found to be overexpressed in breast cancer osseous metastases
relative to primary breast tumours. In addition, ABCC5 was significantly
up-regulated in human and mouse breast cancer cell lines with high
bone-metastatic potential. Stable knockdown of ABCC5 substantially reduced bone
metastatic burden and osteolytic bone destruction in mice. The decrease in
osteolysis was further associated with diminished osteoclast numbers in vivo.
Finally, conditioned media from breast cancer cells with reduced ABCC5
expression failed to induce in vitro osteoclastogenesis to the same extent as
conditioned media from breast cancer cells expressing ABCC5.
CONCLUSIONS:
Our data suggests that
ABCC5 functions as a mediator of breast cancer skeletal metastasis. ABCC5
expression in breast cancer cells is important for efficient
osteoclast-mediated bone resorption. Hence, ABCC5 may be a potential
therapeutic target for breast cancer bone metastasis.
Source: ABCC5
supports osteoclast formation and promotes breast cancer metastasis to bone
Mourskaia AA, Amir E, Dong Z, Tiedemann K, Cory S, Omeroglu A, Bertos N,
Ouellet V, Clemons M, Scheffer GL, Park M, Hallett M, Komarova SV, Siegel PM (peter.siegel@mcgill.ca). Breast Cancer
Res. 2012 Nov 22;14(6):R149.
Free paper available at:
Aucun commentaire:
Enregistrer un commentaire